TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21557368

Group type: EXPERIMENTAL
Intervention: Neutral gadolinium diethylenetriaminepentaacetic acid bis‐methylamide (0.1 mmol/kg)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Ionic gadolinium diethylenetriaminepentaacetic acid (0.1 mmol/kg)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Comparison of normalized Cho between groups A and B
Number of subjects: 63
Study: 19241200

Group type: EXPERIMENTAL
Intervention: Modified wheelchair with ESP steering conversion kit
Number of subjects: 13

Group type: COMPARATOR
Intervention: Standard dual handrim Sunrise Breezy wheelchair
Number of subjects: 13
Study: 17601896

Group type: EXPERIMENTAL
Intervention: Ceftriaxone plus azithromycin (1 g per week for 2 weeks)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Ceftriaxone plus doxycycline (200 mg/d for 2 weeks)
Number of subjects: 106
Study: 15466978

Group type: EXPERIMENTAL
Intervention: Cigarette reduction (75% reduction over 6 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1-Hydroxypyrene
Number of subjects: 0
Study: 11133600

Group type: EXPERIMENTAL
Intervention: Oral clonidine (4 microg/kg)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Oral midazolam (0.5 mg/kg)
Number of subjects: 134
Study: 9754085

Group type: EXPERIMENTAL
Intervention: Combination of 5-fluorouracil (5-FU) and 70% glycolic acid (GA)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Glycolic acid (GA) alone
Number of subjects: 18
Study: 8151586

Group type: EXPERIMENTAL
Intervention: Bucillamine (100 mg/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (inactive)
Number of subjects: 24
Study: 3047337

Group type: EXPERIMENTAL
Intervention: Chemotherapy (exact regimen not specified)
Number of subjects: 259
Study: 1747791

Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil (5FU) administered as a protracted venous infusion
Number of subjects: 522
Study: 1036806

Group type: EXPERIMENTAL
Intervention: Subcutaneous low-dose heparin
Number of subjects: 143
Study: 30167975

Group type: EXPERIMENTAL
Intervention: Multiple exercise therapy (training and stretching the knee and hip muscles)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control therapy (training the quadriceps muscles)
Number of subjects: 100
Study: 27438460

Group type: EXPERIMENTAL
Intervention: Depression alleviation
Number of subjects: 1028
Study: 25582141

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel plus gemcitabine
Number of subjects: 0

Group type: COMPARATOR
Intervention: gemcitabine alone
Number of subjects: 0
Study: 24335178

Group type: EXPERIMENTAL
Intervention: NAC+LRH (4 cycles of cisplatin, paclitaxel, and carboplatin)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: NAC+LRH
Number of subjects: 21

Group type: COMPARATOR
Intervention: LRH
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cisplatin (part of NAC)
Number of subjects: 21
Study: 22162990

Group type: EXPERIMENTAL
Intervention: Short-term stress management training
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study: 19656254

Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Radiofrequency (RF) ablation
Number of subjects: 40
Study: 17824884

Group type: EXPERIMENTAL
Intervention: Topical dry mouth products containing olive oil, betaine, and xylitol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal dry mouth routine care
Number of subjects: 40
Study: 15922429

Group type: EXPERIMENTAL
Intervention: SWL plus PDI therapy (median of four sessions, range 1 to 12)
Number of subjects: 108

Group type: COMPARATOR
Intervention: SWL only
Number of subjects: 108
Study: 11159235

Group type: EXPERIMENTAL
Intervention: Bulb test
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Syringe test
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: ETCO(2) monitoring
Number of subjects: 48

Group type: COMPARATOR
Intervention: Bulb test and Syringe test
Number of subjects: 48
Study: 9040453

Group type: EXPERIMENTAL
Intervention: Nitrendipine (10 to 40 mg/d) with possible addition of enalapril (5 to 20 mg/d) and/or hydrochlorothiazide (12.5 to 25 mg/d)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Smoothing techniques (moving or fixed 2-hour averages or Fourier modeling)
Number of subjects: 244
Study: 7943517

Group type: EXPERIMENTAL
Intervention: Isokinetic concentric training
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isokinetic eccentric training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group with no training
Number of subjects: 30
Study: 3227054

Group type: EXPERIMENTAL
Intervention: High-dose haloperidol (0.40 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose haloperidol (0.15 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Test dose haloperidol (0.05 mg/kg)
Number of subjects: 0
Study: 29455556

Group type: EXPERIMENTAL
Intervention: Computer-assisted ultrasound guidance
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional ultrasound guidance
Number of subjects: 71
Study: 28898532

Group type: EXPERIMENTAL
Intervention: PPV plus HM
Number of subjects: 70

Group type: COMPARATOR
Intervention: PPV alone
Number of subjects: 70
Study: 25983115

Group type: EXPERIMENTAL
Intervention: Warm arthroscopic irrigation fluid (Group W)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Room temperature irrigation fluid (Group RT)
Number of subjects: 66
Study: 23403428

Group type: EXPERIMENTAL
Intervention: Daclatasvir (DCV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 22006023

Group type: EXPERIMENTAL
Intervention: Darifenacin 7.5 mg once daily
Number of subjects: 1059

Group type: EXPERIMENTAL
Intervention: Darifenacin 15 mg once daily
Number of subjects: 1059

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1059
Study: 19199510

Group type: COMPARATOR
Intervention: 780-nm laser phototherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laser phototherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laser irradiation in cell cultures
Number of subjects: 0
Study: 16198072

Group type: EXPERIMENTAL
Intervention: Estradiol (2 mg) and Norethisterone acetate (1 mg) daily for 6 months
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 15458803

Group type: EXPERIMENTAL
Intervention: Television viewing
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Auditory stimulus (listening to a recorded story)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control conditions (no environmental stimuli)
Number of subjects: 48
Study: 10800757

Group type: EXPERIMENTAL
Intervention: pure human FSH: 75 IU i.m. every other day for 3 months
Number of subjects: 183

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 183
Study: 8607890

Group type: EXPERIMENTAL
Intervention: High-intensity progressive resistance training (RA group)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-intensity progressive resistance training (young exercise group)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-intensity progressive resistance training (elderly exercise group)
Number of subjects: 8
Study: 2005294

Group type: EXPERIMENTAL
Intervention: Home-based treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Out-patient clinic treatment
Number of subjects: 0
Study: 6097137

Group type: EXPERIMENTAL
Intervention: Atracurium 0.4 mg/kg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Atracurium 0.5 mg/kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Suxamethonium 1.0 mg/kg
Number of subjects: 30
Study: 29787859

Group type: EXPERIMENTAL
Intervention: Synbiotic (prebiotic: fructooligosaccharides 4 g/day; probiotic: Bifidobacterium animalis subsp. lactis BB-12 at a minimum of 10 billion CFU/day)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Synbiotic
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 27009579

Group type: EXPERIMENTAL
Intervention: High systolic blood pressure (SBP) in participants aged 70 years
Number of subjects: 1973

Group type: EXPERIMENTAL
Intervention: Uncontrolled blood pressure in participants aged 70 years
Number of subjects: 1973

Group type: EXPERIMENTAL
Intervention: High systolic blood pressure (SBP) in participants aged 80 years
Number of subjects: 1973

Group type: EXPERIMENTAL
Intervention: Nutritional status indicators (serum albumin, frequency of going outdoors) in participants aged 80 years
Number of subjects: 1973
Study: 25684233

Group type: EXPERIMENTAL
Intervention: Vanoxerine 200 mg
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Vanoxerine 300 mg
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Vanoxerine 400 mg
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study: 24172120

Group type: EXPERIMENTAL
Intervention: Alcohol (0.4 g/kg)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 20859556

Group type: EXPERIMENTAL
Intervention: Mandibular implant-supported overdentures (IOD)
Number of subjects: 1

Group type: COMPARATOR
Intervention: Denture abstention
Number of subjects: 1
Study: 19038680

Group type: EXPERIMENTAL
Intervention: CRT-ON (Cardiac Resynchronization Therapy)
Number of subjects: 610

Group type: COMPARATOR
Intervention: CRT-OFF (Control)
Number of subjects: 610
Study: 16166875

Group type: EXPERIMENTAL
Intervention: Patient-Centered Advance Care Planning (PC-ACP)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 32
Study: 12849769

Group type: EXPERIMENTAL
Intervention: Intentional semantic battery
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Automatic semantic priming task
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intentional semantic tasks
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Automatic semantic tasks
Number of subjects: 21
Study: 10623399

Group type: EXPERIMENTAL
Intervention: $5 check included in the mailer
Number of subjects: 400

Group type: COMPARATOR
Intervention: No compensation
Number of subjects: 400

Group type: COMPARATOR
Intervention: Telephone follow-up
Number of subjects: 400

Group type: COMPARATOR
Intervention: No follow-up call
Number of subjects: 400
Study: 8664205

Group type: EXPERIMENTAL
Intervention: Vigilance-plus-memory training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Vigilance training alone
Number of subjects: 40
Study: 2309544

Group type: EXPERIMENTAL
Intervention: Alfentanil 20 micrograms/kg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 30
Study: 506742

Group type: EXPERIMENTAL
Intervention: 100 mg zimelidine
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 25 mg imipramine
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 50 mg chlorimipramine
Number of subjects: 3
Study: 31336289

Group type: EXPERIMENTAL
Intervention: Annual LDCT screening
Number of subjects: 2376

Group type: COMPARATOR
Intervention: Biennial LDCT screening
Number of subjects: 2376
Study: 28899412

Group type: EXPERIMENTAL
Intervention: Leaflet with detailed information on the benefits and harms of screening
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard leaflet that does not mention harms
Number of subjects: 400
Study: 25886483

Group type: EXPERIMENTAL
Intervention: Acupuncture, electroacupuncture, and intradermal acupuncture
Number of subjects: 80

Group type: COMPARATOR
Intervention: Mock transcutaneous electrical nerve stimulation and sham intradermal acupuncture
Number of subjects: 80
Study: 23743879

Group type: EXPERIMENTAL
Intervention: Multicomponent support programme for caregivers (2-week rehabilitation period)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Multicomponent support programme for caregivers
Number of subjects: 135
Study: 21167235

Group type: EXPERIMENTAL
Intervention: Terlipressin plus albumin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (albumin alone)
Number of subjects: 0
Study: 19700936

Group type: EXPERIMENTAL
Intervention: Tulobuterol patch (TP) at 2mg/day plus ICS
Number of subjects: 89

Group type: COMPARATOR
Intervention: Slow-release theophylline (SRT)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Leukotriene receptor antagonist (LTRA)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (ICS alone)
Number of subjects: 89
Study: 17760494

Group type: EXPERIMENTAL
Intervention: Morphine (intravenous injection)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Codeine (intramuscular route)
Number of subjects: 0
Study: 15010197

Group type: EXPERIMENTAL
Intervention: Verbal Rating Scale (VRS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Visual Analog Scale (VAS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Numerical Rating Score (NRS)
Number of subjects: 20
Study: 11251433

Group type: EXPERIMENTAL
Intervention: Propofol target-concentration infusion (4 mg.l‐1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 8% sevoflurane inhalation with 50% nitrous oxide
Number of subjects: 50
Study: 9758026

Group type: EXPERIMENTAL
Intervention: Continuous lateral rotational therapy (CLRT) <40 degrees
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control periods (supine and stationary)
Number of subjects: 13
Study: 8993096

Group type: EXPERIMENTAL
Intervention: Glycine (0.4-0.8 g/kg/day) added to neuroleptics
Number of subjects: 0
Study: 2248106

Group type: EXPERIMENTAL
Intervention: Nicotine gum users
Number of subjects: 1096

Group type: COMPARATOR
Intervention: Nicotine gum non-users
Number of subjects: 1096

Group type: EXPERIMENTAL
Intervention: Abstainers
Number of subjects: 1096

Group type: COMPARATOR
Intervention: Relapsers
Number of subjects: 1096

Group type: EXPERIMENTAL
Intervention: Overall weight change
Number of subjects: 1096

Group type: EXPERIMENTAL
Intervention: Cigarette consumption
Number of subjects: 1096

Group type: COMPARATOR
Intervention: Abstainers who relapsed vs maintained abstinence
Number of subjects: 1096
Study: 6448210

Group type: EXPERIMENTAL
Intervention: Amipaque (metrizamide)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hexabrix (ioxaglic acid)
Number of subjects: 0
Study: 30681717

Group type: EXPERIMENTAL
Intervention: Intuitive approach (cognitive load, immediate response)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Deliberative approach (no cognitive load, careful thought)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Intuitive approach
Number of subjects: 199

Group type: COMPARATOR
Intervention: Deliberative approach
Number of subjects: 199
Study: 28522757

Group type: EXPERIMENTAL
Intervention: Speckle tracking ultrasound
Number of subjects: 13

Group type: COMPARATOR
Intervention: Conventional ultrasound techniques
Number of subjects: 13
Study: 26214848

Group type: EXPERIMENTAL
Intervention: Self-report adherence assessment
Number of subjects: 696

Group type: COMPARATOR
Intervention: Smart blister packs adherence assessment
Number of subjects: 696
Study: 23683608

Group type: EXPERIMENTAL
Intervention: Acetazolamide (ACTZ) 500 mg administered intravenously to healthy subjects (HV)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Acetazolamide (ACTZ) 500 mg administered intravenously to peritoneal dialysis patients (CAPD)
Number of subjects: 15
Study: 20623036

Group type: EXPERIMENTAL
Intervention: Immediate occlusal loading
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Immediate non-occlusal loading
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Immediate post-extractive implants
Number of subjects: 40

Group type: COMPARATOR
Intervention: Delayed implants
Number of subjects: 40
Study: 18997540

Group type: EXPERIMENTAL
Intervention: SofLens 38
Number of subjects: 24

Group type: COMPARATOR
Intervention: OASYS
Number of subjects: 24

Group type: COMPARATOR
Intervention: ADVANCE
Number of subjects: 24

Group type: COMPARATOR
Intervention: NIGHT & DAY
Number of subjects: 24
Study: 16618980

Group type: EXPERIMENTAL
Intervention: nateglinide (270 mg/day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: voglibose (0.6 mg/day)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: nateglinide
Number of subjects: 29

Group type: COMPARATOR
Intervention: voglibose
Number of subjects: 29
Study: 14743120

Group type: COMPARATOR
Intervention: General Anesthesia (Group A)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Combined Anesthesia (Group B)
Number of subjects: 70
Study: 11201870

Group type: EXPERIMENTAL
Intervention: Lepromatous patients without ENL
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Tuberculoid leprosy patients
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Patients with ENL
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Lepromatous patients with ENL
Number of subjects: 130
Study: 8725991

Group type: EXPERIMENTAL
Intervention: Risperidone (6 mg)
Number of subjects: 15
Study: 1683365

Group type: EXPERIMENTAL
Intervention: CPAP therapy
Number of subjects: 55

Group type: COMPARATOR
Intervention: High-flow face mask oxygen therapy (control)
Number of subjects: 55
Study: 7054205

Group type: EXPERIMENTAL
Intervention: 1.2 grams of aspirin (low dose)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: 3.6 grams of aspirin (high dose)
Number of subjects: 182
Study: 31279331

Group type: EXPERIMENTAL
Intervention: Wolf-Motor-Function-Test-Orthopaedic (WMFT-O)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Disability of the Arm, Shoulder and Hand (DASH)
Number of subjects: 56
Study: 28987723

Group type: EXPERIMENTAL
Intervention: Aspirin (100mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 50
Study: 26514303

Group type: EXPERIMENTAL
Intervention: Perindopril (4mg)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (25mg)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Indapamide (1.5mg)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control (baseline)
Number of subjects: 88
Study: 24720535

Group type: EXPERIMENTAL
Intervention: Simvastatin (S)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Simvastatin + Ezetimibe (S+E)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (placebo run-in)
Number of subjects: 39
Study: 22718810

Group type: EXPERIMENTAL
Intervention: Olmesartan 20 mg/day + Azelnidipine 16 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Candesartan 8 mg/day + Amlodipine 5 mg/day
Number of subjects: 0
Study: 19011838

Group type: EXPERIMENTAL
Intervention: Adderall
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 17586304

Group type: EXPERIMENTAL
Intervention: High-dose vitamin A supplementation
Number of subjects: 220

Group type: COMPARATOR
Intervention: WHO standard vitamin A supplementation
Number of subjects: 220
Study: 15482975

Group type: EXPERIMENTAL
Intervention: Bupropion SR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11457420

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 14
Study: 9738674

Group type: EXPERIMENTAL
Intervention: Clobazam (CLB)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Carbamazepine (CBZ)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Phenytoin (PHT)
Number of subjects: 235
Study: 8302071

Group type: EXPERIMENTAL
Intervention: 50 ml/min
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 75 ml/min
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 100 ml/min
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 200 ml/min
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 300 ml/min
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 500 ml/min
Number of subjects: 62

Group type: COMPARATOR
Intervention: Low flow groups (50, 75, 100 ml/min)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: High flow groups (200, 300 ml/min)
Number of subjects: 62
Study: 3291548

Group type: EXPERIMENTAL
Intervention: Pressure reducing medical therapy
Number of subjects: 15

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 15
Study: 31774464

Group type: EXPERIMENTAL
Intervention: Ipilimumab (10 mg/kg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ipilimumab (3 mg/kg or 10 mg/kg)
Number of subjects: 32
Study: 31340226

Group type: EXPERIMENTAL
Intervention: PUI + NaOCl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PUI + CHXg+SS
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PUI + CHXs
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PUI + SS
Number of subjects: 60
Study: 28143504

Group type: EXPERIMENTAL
Intervention: Positive Therapeutic Alliance group (counseling and guidance with emphasis on therapeutic alliance and empathy)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Usual Treatment group (same information and counseling with limited interaction with the therapist)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 222
Study: 26286486

Group type: EXPERIMENTAL
Intervention: Personalised email invitation
Number of subjects: 344

Group type: COMPARATOR
Intervention: Generic email invitation
Number of subjects: 344
Study: 23167442

Group type: EXPERIMENTAL
Intervention: Alcohol expectancy (glass of beer/wine)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Water (control group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tobacco devaluation (health warnings and smoking satiety)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Nominal Pavlovian to instrumental transfer (PIT) test
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Reacquisition test with direct feedback from outcomes
Number of subjects: 80
Study: 21238572

Group type: EXPERIMENTAL
Intervention: Liquid formulation of RIX4414
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lyophilized formulation of RIX4414
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18617536

Group type: EXPERIMENTAL
Intervention: Gastrectomy plus chemotherapy
Number of subjects: 330

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 330
Study: 17314754

Group type: EXPERIMENTAL
Intervention: Cisplatin plus docetaxel
Number of subjects: 150

Group type: COMPARATOR
Intervention: Cisplatin plus gemcitabine
Number of subjects: 150
Study: 12928049

Group type: EXPERIMENTAL
Intervention: LPS-stimulated blood cells from AD patients
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: LPS-stimulated blood cells from mild and moderate AD patients
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: IL-1beta, IL-6, and TNF-alpha secretion
Number of subjects: 32

Group type: COMPARATOR
Intervention: Age-related controls
Number of subjects: 32